Amitgiri Goswami

发表

Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agent.

P. Patil, H. Patel, Suresh R. Giri, 2008, Bioorganic & medicinal chemistry letters.

Efficient Synthesis of Structurally Novel Diaryl Ethers by Regioselective Functionalization

B. Pandey, Mukul R Jain, P. Patel, 2008 .

Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: synthesis, biological evaluation, and molecular modeling in the homology model.

Bhupendra Mishra, B. Pandey, Bhupendra Mishra, 2007, Journal of medicinal chemistry.

Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents.

Suresh R. Giri, Mukul R Jain, P. Patel, 2011, Bioorganic & medicinal chemistry letters.

Convenient Synthesis of Structurally Novel 1,3‐Disubstituted Azetidine Derivatives

Mukul R Jain, P. Patel, Amitgiri Goswami, 2008 .

Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.

P. Mitra, Bhupendra Mishra, Jayendra Z. Patel, 2008, Bioorganic & medicinal chemistry letters.

An Efficient and Scalable Synthesis of tert-Butyl (3aR,6aS)-5-Oxohexahydrocyclo penta[c]pyrrole-2(1H)-carboxylate: A Pharmacologically Important Intermediate

P. Jadav, R. Bahekar, Dipam N Patel, 2017 .

2D MoS2: structure, mechanisms and photocatalytic applications

S. Pillai, Parnia Forouzandeh, Kris O’Dowd, 2021 .

Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors.

D. Bandyopadhyay, Mukul R Jain, P. Jadav, 2022, Bioorganic chemistry.

Measurement of gases (O2, CO2, N2, N2O and volatile agents)

Amitgiri Goswami, Robin L Cooper, 2011 .

Bioisosteric replacement of dihydropyrazole of 4S-(-)-3-(4-chlorophenyl)-N-methyl-N'-[(4-chlorophenyl)-sulfonyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-caboxamidine (SLV-319) a potent CB1 receptor antagonist by imidazole and oxazole.

Bhupendra Mishra, Jayendra Z. Patel, Mukul R Jain, 2008, Bioorganic & Medicinal Chemistry Letters.

Revisiting glitazars: thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents.

Suresh R. Giri, Mukul R Jain, P. Patel, 2011, Bioorganic & medicinal chemistry letters.